Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM)

Historical Holders from Q3 2020 to Q1 2025

Symbol
OM on Nasdaq
CUSIP
690145107
Type / Class
Equity / Common Stock, par value $0.001 per share (the "Shares")
Shares outstanding
266M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
21.1M
Holdings value
$23.4M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
74
Number of buys
23
Number of sells
-40
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Durable Capital Partners LP 9.9% $14.6M 26.6M Durable Capital Partners LP Jan 3, 2025
PFM Health Sciences, LP 9.4% $13.8M 25M PFM Health Sciences, LP Mar 10, 2025
PERCEPTIVE ADVISORS LLC 9.5% $3.09M 5.63M Perceptive Advisors LLC Jan 8, 2025
FMR LLC 7% $2.02M 3.67M FMR LLC Dec 31, 2024
VANGUARD GROUP INC 4.96% $1.43M 2.61M The Vanguard Group Dec 31, 2024

Institutional Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 0 $0 -$381K 0
2024 Q4 21.1M $23.4M -$3.64M $1.11 74
2024 Q3 26.1M $17.6M -$39.7M $0.68 76
2024 Q2 48.6M $187M -$3.41M $3.85 118
2024 Q1 50M $111M -$22.7M $2.22 108
2023 Q4 52.2M $282M -$71.6M $5.41 135
2023 Q3 52.7M $573M -$1.99M $10.88 148
2023 Q2 52M $1.14B +$26.2M $21.87 151
2023 Q1 51.1M $939M +$47.7M $18.40 157
2022 Q4 49M $1.26B +$454K $25.82 145
2022 Q3 47.3M $752M -$60.2M $15.93 126
2022 Q2 48.5M $720M -$164M $14.86 141
2022 Q1 51.3M $2.33B +$123M $45.40 146
2021 Q4 45.5M $2.1B -$211M $46.09 152
2021 Q3 50.7M $2.51B +$213M $49.44 138
2021 Q2 46.3M $2.31B +$390M $49.98 126
2021 Q1 38.4M $2.09B +$50.1M $54.39 109
2020 Q4 37.4M $2.09B +$69.5M $56.84 108
2020 Q3 35.9M $1.75B +$1.75B $50.00 82